Epigenetic modulators as therapeutic targets in prostate cancer
Inês Graça(Polytechnic Institute of Porto), Cármen Jerónimo(Universidade do Porto)
Cited by 90
Related Papers
Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests
|Cells|2023|95
Anti-neoplastic properties of hydralazine in prostate cancer
|Oncotarget|2014|63
Improved recovery of urinary small extracellular vesicles by differential ultracentrifugation
|Scientific Reports|2024|23